Nagy, N.; Bói, B.; Papp, G.; Fiák, E.; Gáspár-Kiss, E.; Perge, B.; Farmasi, N.; Tarr, T.
Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus. Biomedicines 2024, 12, 530.
https://doi.org/10.3390/biomedicines12030530
AMA Style
Nagy N, Bói B, Papp G, Fiák E, Gáspár-Kiss E, Perge B, Farmasi N, Tarr T.
Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus. Biomedicines. 2024; 12(3):530.
https://doi.org/10.3390/biomedicines12030530
Chicago/Turabian Style
Nagy, Nikolett, Bernadett Bói, Gábor Papp, Edit Fiák, Eszter Gáspár-Kiss, Bianka Perge, Nikolett Farmasi, and Tünde Tarr.
2024. "Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus" Biomedicines 12, no. 3: 530.
https://doi.org/10.3390/biomedicines12030530
APA Style
Nagy, N., Bói, B., Papp, G., Fiák, E., Gáspár-Kiss, E., Perge, B., Farmasi, N., & Tarr, T.
(2024). Antiphospholipid Antibodies Are Major Risk Factors for Non-Thrombotic Cardiac Complications in Systemic Lupus Erythematosus. Biomedicines, 12(3), 530.
https://doi.org/10.3390/biomedicines12030530